Search Results

Site Search

Communique - Insights

Communiqué takes a deep dive into how Mayo Clinic Laboratories advances patient care, research, and education through laboratory medicine. Our experts are solving the most serious and complex medical challenges for patients worldwide.

Future Direction of Lab Medicine - Insights

Looking into the future of laboratory medicine and pathology and providing insight into the direction its heading.

MCL Hereditary Peripheral Neuropathy Flyer MC2775648

MCL Hereditary Peripheral Neuropathy Flyer HEREDITARY PERIPHERAL NEUROPATHY SIMPLIFY IMPROVE DIAGNOSIS PHENOTYPIC FOCUSED TESTING Hereditary peripheral neuropathies diverse group disorders

December 2022 - Pulmonary - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Pulmonary Pathology.

Complex testing offers answers and guidance about a lifelong illness - Insights

For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...

Patient spotlight - Insights

Patients are at the heart of all we do at Mayo Clinic Laboratories. Our laboratory testing can clear the fog of an uncertain diagnosis, point to the next steps in care, and pave the way for better treatment. Our work makes a difference in...

MCL Additional Specimen MC4091248

MCL Additional Specimen Complete print Additional Specimen Reset Form Instructions form sending additional specimen order

NB Gaucher (1).pdf

MAYO CLINIC LABORATORIES Newborn Screen Follow-up for Gaucher Disease GBA activity - decreased Glucopsychosine - elevated Gaucher disease confirmed Referral to Genetics Specialist Newborn screen result: decreased beta-glucosidase*...

Nicotine - Insights

Learn more about Mayo Clinic Laboratories’ testing to identify and monitor nicotine use as part of a patient’s nicotine-use cessation treatment plan, before anesthesia/surgery, or as part of insurance policy assessments.

ashi-hla-lab-az.pdf

I AS AMERICAN SOCIETY FO HISTOCOMPATIBILITY & IMMUNOGENETICS ASHI# THE AMERICAN SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS CERTIFIES THAT Mayo Clinic Hospital HLA Laboratory 10-6-AZ-04-1 CLIA # UNDER THE DIRECTION OF...